Table 4 Menopausal symptoms reported at screening
US Participants | EU Participants | |||||
|---|---|---|---|---|---|---|
Dallas, TX (n = 9) | Chicago, IL (n = 7) | Total US (N = 16) | UK (n = 8) | France (n = 8) | Total EU (N = 16) | |
Age at VMS onset, mean (SD), y | 46.2 (6.2) | 49.9 (5.3) | 47.8 (5.9) | 48.3 (4.4) | 48.9 (4.0) | 48.6 (4.1) |
Average weekly number of moderate to severe VMS,a mean (SD) | ||||||
Moderate | 34.1 (15.2) | 27.1 (13.9) | 30.9 (14.5) | 40.3 (19.0) | 25.0 (28.7) | 32.6 (24.8) |
Severe | 27.2 (23.3) | 31.7 (27.7) | 29.2 (24.5) | 25.4 (22.7) | 44.1 (21.4) | 34.8 (23.4) |
Other menopausal symptoms at screening,b n (%) | ||||||
Problems sleeping | 8 (88.9) | 7 (100) | 15 (93.8) | 6 (75.0) | 6 (75.0) | 12 (75.0) |
Mood swings | 6 (66.7) | 2 (28.6) | 8 (50.0) | 6 (75.0) | 6 (75.0) | 12 (75.0) |
Weight gain | 7 (77.8) | 7 (100) | 14 (87.5) | 5 (62.5) | 6 (75.0) | 11 (68.8) |
Vaginal dryness | 6 (66.7) | 4 (57.1) | 10 (62.5) | 4 (50.0) | 4 (50.0) | 8 (50.0) |
Memory/concentration problems | 5 (55.6) | 3 (42.9) | 8 (50.0) | 7 (87.5) | 0 | 7 (43.8) |
Headaches | 4 (44.4) | 3 (42.9) | 7 (43.8) | 5 (62.5) | 2 (25.0) | 7 (43.8) |
Depression | 3 (33.3) | 1 (14.3) | 4 (25.0) | 1 (12.5) | 0 | 1 (6.3) |